These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15062939)

  • 1. Investigation of sandwiched gadolinium (III) complexes with tungstosilicates as potential MRI contrast agents.
    Sun G; Feng J; Wu H; Pei F; Fang K; Lei H
    Magn Reson Imaging; 2004 Apr; 22(3):421-6. PubMed ID: 15062939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The gadolinium complexes with polyoxometalates as potential MRI contrast agents.
    Li Z; Li W; Li X; Pei F; Li Y; Lei H
    Magn Reson Imaging; 2007 Apr; 25(3):412-7. PubMed ID: 17371733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral blood volume quantification in a C6 tumor model using gadolinium per (3,6-anhydro) alpha-cyclodextrin as a new magnetic resonance imaging preclinical contrast agent.
    Lahrech H; Perles-Barbacaru AT; Aous S; Le Bas JF; Debouzy JC; Gadelle A; Fries PH
    J Cereb Blood Flow Metab; 2008 May; 28(5):1017-29. PubMed ID: 18183033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
    Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Separation and characterization of the two diastereomers for [Gd(DTPA-bz-NH2)(H2O)]2-, a common synthon in macromolecular MRI contrast agents: their water exchange and isomerization kinetics.
    Burai L; Tóth E; Sour A; Merbach AE
    Inorg Chem; 2005 May; 44(10):3561-8. PubMed ID: 15877439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization, and pharmacokinetic evaluation of a potential MRI contrast agent containing two paramagnetic centers with albumin binding affinity.
    Parac-Vogt TN; Kimpe K; Laurent S; Vander Elst L; Burtea C; Chen F; Muller RN; Ni Y; Verbruggen A; Binnemans K
    Chemistry; 2005 May; 11(10):3077-86. PubMed ID: 15776492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of gadolinium complexes based on PAMAM as MRI contrast agents.
    Yan GP; Hu B; Liu ML; Li LY
    J Pharm Pharmacol; 2005 Mar; 57(3):351-7. PubMed ID: 15807991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging enhancement of normal tissues and tumors using macromolecular Gd-based cascade polymer contrast agents: preclinical evaluations.
    Raatschen HJ; Fu Y; Shames DM; Wendland MF; Brasch RC
    Invest Radiol; 2006 Dec; 41(12):860-7. PubMed ID: 17099424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lanthanide chelates of (bis)-hydroxymethyl-substituted DTTA with potential application as contrast agents in magnetic resonance imaging.
    Silvério S; Torres S; Martins AF; Martins JA; André JP; Helm L; Prata MI; Santos AC; Geraldes CF
    Dalton Trans; 2009 Jun; (24):4656-70. PubMed ID: 19513474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of size and charge on pharmacokinetics and in vivo MRI contrast enhancement of biodegradable polydisulfide Gd(III) complexes.
    Zong Y; Guo J; Ke T; Mohs AM; Parker DL; Lu ZR
    J Control Release; 2006 May; 112(3):350-6. PubMed ID: 16631270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing lesions of the brain: intraindividual crossover comparison of contrast enhancement after gadobenate dimeglumine versus established gadolinium comparators.
    Essig M; Tartaro A; Tartaglione T; Pirovano G; Kirchin MA; Spinazzi A
    Acad Radiol; 2006 Jun; 13(6):744-51. PubMed ID: 16679277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
    Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB
    Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of [Gd(Bz-TTDA)]2- as a potential contrast agent in MR imaging of the hepatobiliary system: an animal study.
    Hsu JS; Jaw TS; Liu GC; Wang YM; Chen SH; Kuo YT; Jao JC; Li CW; Tsai KB
    J Magn Reson Imaging; 2004 Oct; 20(4):632-9. PubMed ID: 15390149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facile synthesis and relaxation properties of novel bispolyazamacrocyclic Gd3+ complexes: an attempt towards calcium-sensitive MRI contrast agents.
    Mishra A; Fousková P; Angelovski G; Balogh E; Mishra AK; Logothetis NK; Tóth E
    Inorg Chem; 2008 Feb; 47(4):1370-81. PubMed ID: 18166011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A benzene-core trinuclear GdIII complex: towards the optimization of relaxivity for MRI contrast agent applications at high magnetic field.
    Livramento JB; Helm L; Sour A; O'Neil C; Merbach AE; Tóth E
    Dalton Trans; 2008 Mar; (9):1195-202. PubMed ID: 18283380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA.
    Tamada T; Ito K; Sone T; Yamamoto A; Yoshida K; Kakuba K; Tanimoto D; Higashi H; Yamashita T
    J Magn Reson Imaging; 2009 Mar; 29(3):636-40. PubMed ID: 19243060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent.
    Wen X; Jackson EF; Price RE; Kim EE; Wu Q; Wallace S; Charnsangavej C; Gelovani JG; Li C
    Bioconjug Chem; 2004; 15(6):1408-15. PubMed ID: 15546209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gadolinium(III)-water hydrogen distance in MRI contrast agents.
    Caravan P; Astashkin AV; Raitsimring AM
    Inorg Chem; 2003 Jun; 42(13):3972-4. PubMed ID: 12817950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon.
    Hanaoka K; Kikuchi K; Terai T; Komatsu T; Nagano T
    Chemistry; 2008; 14(3):987-95. PubMed ID: 17992679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A method for the making and utility of gadolinium-labeled albumin microbubbles.
    Anderson DR; Duryee MJ; Garvin RP; Boska MD; Thiele GM; Klassen LW
    Magn Reson Imaging; 2012 Jan; 30(1):96-103. PubMed ID: 22056512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.